ANVISA issued Resolution 837/2023 on December 15, outlining updated procedures for clinical investigations supporting higher-risk Medical Devices (Classes III and IV) registration.
The main objectives of the new regulation are…
Sorry, this premium content is for RegASK clients only.
Want to access the whole content of the alert or browse all the news?
Subscribe to the latest regulatory news
Curated newsletters
Relevant industry info
Access expert insights
